Home › Funds › Blue Water Life Science Advisors, LP › ADPT
Blue Water Life Science Advisors, LP position in ADPT
ADAPTIVE BIOTECHNOLOGIES COR · Health Care
Blue Water Life Science Advisors, LP reported holding 1,010,145 shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR) in its Q3 2026 13F filing — a position valued at US$29.2M, representing 11.60% of its reported portfolio and ranking #3 among its reported holdings. Blue Water Life Science Advisors, LP has disclosed ADPT holdings in 12 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Blue Water Life Science Advisors, LP's ADPT position evolved
Blue Water Life Science Advisors, LP first disclosed a stake in ADPT in Q3 2023 at 2,377,665 shares (US$13.0M). The position peaked in Q3 2025 at 2,145,145 shares, worth US$32.1M. Across 12 filings, Blue Water Life Science Advisors, LP increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 1,010,145 shares valued at US$29.2M. Notable position changes include a 29% trim in Q4 2023 (shares fell 34% over the following quarter), a 43% trim in Q1 2026 (shares rose 55% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.38M | $12.96M | New |
| Q4 2023 | 1.69M | $8.27M | Reduce |
| Q1 2024 | 1.69M | $5.42M | Hold |
| Q3 2024 | 2.15M | $10.98M | New |
| Q4 2024 | 2.15M | $12.86M | Hold |
| Q1 2025 | 2.15M | $15.94M | Hold |
| Q2 2025 | 2.15M | $24.99M | Hold |
| Q3 2025 | 2.15M | $32.09M | Hold |
| Q4 2025 | 1.77M | $28.67M | Reduce |
| Q1 2026 | 1.01M | $14.02M | Reduce |
| Q2 2026 | 1.01M | $21.67M | Hold |
| Q3 2026 | 1.01M | $29.19M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ADPT and 13F data
ADPT (ADAPTIVE BIOTECHNOLOGIES COR) is a Health Care company. 56 other funds we track also report a position in ADPT — the largest reported positions include Viking Global Investors (US$643.4M), VIKING GLOBAL INVESTORS LP (US$643.4M), Aristotle Atlantic Partners, LLC (US$39.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ADPT
- Viking Global Investors 29.99M sh · $643.37M · Q2 2026
- VIKING GLOBAL INVESTORS LP 29.99M sh · $643.37M · Q2 2026
- Aristotle Atlantic Partners, LLC 1.84M sh · $39.44M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.22M sh · $26.11M · Q2 2026
- Granite Investment Partners, LLC 628.10K sh · $18.15M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 622.89K sh · $18.00M · Q3 2026
More on Blue Water Life Science Advisors, LP
FAQ
How long has Blue Water Life Science Advisors, LP held ADPT?
Blue Water Life Science Advisors, LP has disclosed ADPT holdings in 12 of the last 13 reported quarters, going back to Q3 2023.
What is Blue Water Life Science Advisors, LP's current position in ADPT?
As of Q3 2026, Blue Water Life Science Advisors, LP holds 1.01M shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR), valued at $29.19M, representing 11.60% of its reported portfolio and ranking #3.
Has Blue Water Life Science Advisors, LP been buying or selling ADPT?
In the latest 13F filing (Q3 2026), Blue Water Life Science Advisors, LP held unchanged its position in ADPT. The position peaked in Q3 2025 at 2.15M shares.
Which other funds hold ADPT?
Other major institutional holders of ADPT include Viking Global Investors, VIKING GLOBAL INVESTORS LP, Aristotle Atlantic Partners, LLC, among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.